Compare AKAM & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKAM | ZBH |
|---|---|---|
| Founded | 1998 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 16.0B |
| IPO Year | 1999 | 2001 |
| Metric | AKAM | ZBH |
|---|---|---|
| Price | $119.35 | $90.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 21 |
| Target Price | ★ $107.87 | $101.00 |
| AVG Volume (30 Days) | ★ 3.8M | 2.0M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.71 | ★ 1.22 |
| Revenue | $2,502,996,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $8.53 | $4.96 |
| Revenue Next Year | $7.09 | $3.76 |
| P/E Ratio | $168.83 | ★ $71.78 |
| Revenue Growth | 6.96 | ★ 7.20 |
| 52 Week Low | $69.79 | $79.12 |
| 52 Week High | $165.45 | $108.29 |
| Indicator | AKAM | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 34.74 | 59.75 |
| Support Level | $87.55 | $85.50 |
| Resistance Level | $165.13 | $90.50 |
| Average True Range (ATR) | 6.64 | 2.03 |
| MACD | -3.61 | 0.23 |
| Stochastic Oscillator | 2.62 | 86.19 |
Akamai operates a content delivery network, in which customers store content on distributed servers to deliver it to their own customers more quickly. Akamai has over 350,000 servers distributed over 4,350 points of presence in more than 700 cities globally. This network supports upward of 20% of global internet traffic, generating massive amounts of data. Using data generated by the delivery network, the firm offers cybersecurity products and cloud computing services, ranging from API security to zero-trust enterprise access, which has surpassed the delivery network in revenue and importance. As of 2026, the primary focus has shifted to offering computing hardware as a service, with an emphasis on serving large language model providers such as Anthropic.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.